News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Elsevier’s revenue: £2.9 billion – Melanie Conrad
Photo of Melanie Conrad from imh.charite.de
Jul 21, 2023, 18:21

Elsevier’s revenue: £2.9 billion – Melanie Conrad

Elsevier’s revenue: £2.9 billion. WTF? We scientists produce the content for manuscripts and review for free. Then we pay huge fees for open access publishing. Science should not be business. What on earth can we do to fight against this?

For details: Click here

Source: Melanie Conrad/Twitter

cancer Elsevier manuscripts Melanie Conrad OncoDaily Oncology scientists
Special Coverage
Blog
Oct 5, 2024, 11:04
Mazyar Shadman: Accepting application for BMT/Immunotherapy fellowship at Fred Hutchinson Cancer Center
Blog
Oct 5, 2024, 11:01
Why we need more basic scientists in supportive care and survivorship research - MASCC
Blog
Oct 5, 2024, 10:59
Zainab Shinkafi-Bagudu: Africa has a voice - Breaking down barriers
Blog
Oct 5, 2024, 10:59
Diogo Martins Branco: ESMO Reimbursement Model
Blog
Oct 5, 2024, 10:56
Carnell Jermaine Hampton: FMEA technique to investigate and improve the approach to Total Body Irradiation
Blog
Oct 5, 2024, 10:53
Chris Chukwunyere: Sharing Insights on Community-Based Participatory Research at the PRECISE Symposium
Blog
Oct 5, 2024, 10:39
Anna-Elina Rahikainen: Thank you IPOS for the opportunity to present
Blog
Oct 5, 2024, 09:50
Jashodeep Datta Named Principal Investigator for $2.5M NCI R37 MERIT Grant
Blog
Oct 5, 2024, 09:30
Medicaid expansion increased use of adjuvant therapy for NSCLC
Insight
Oct 5, 2024, 09:27
Patricia P. Falconer: Patients residing in rural communities have more barriers to care and a higher risk of financial toxicity
Blog
Oct 5, 2024, 09:26
Emily Holthuis: Expanding Partnerships with Patients and Carers in the EORTC
Blog
Oct 5, 2024, 09:24
Andreas Brandl: Prophylactic use of HIPEC in T4 colorectal cancer at ESSO43